Oncology & Cancer

Scientists unveil prostate cancer's 'Rosetta Stone'

Almost 90 per cent of men with advanced prostate cancer carry genetic mutations in their tumours that could be targeted by either existing or new cancer drugs, a landmark new study reveals.

Oncology & Cancer

Researchers link genetic marker to rectal cancer treatment

A team of researchers led by Keck School of Medicine of the University of Southern California (USC) oncologist Heinz-Josef Lenz, M.D., has identified a genetic marker that may predict which patients with rectal cancer can ...

Neuroscience

A light switch inside the brain

Activating and deactivating individual nerve cells in the brain is something many neuroscientists wish they could do, as it would help them to better understand how the brain works.

Oncology & Cancer

Researchers develop breast cancer prediction tool for black women

The lack of a breast cancer risk prediction model tailored to Black women represents a critical gap, given that U.S. Black women, on average, are more likely to have breast cancer at earlier ages and with a worse prognosis ...

Medical research

Preventing the onset of schizophrenia in a mouse model

Although predisposing processes occur earlier, schizophrenia emerges at young adulthood, suggesting it might involve a pathological transition during late brain development in predisposed individuals. Using a genetic mouse ...

Oncology & Cancer

New tumor suppressor gene identified

A recent study published in Clinical Cancer Research suggests that the protein hVps37A suppresses tumor growth in ovarian cancer. The work, which was funded by the Austrian Science Fund FWF, shows, for the first time, that ...

page 18 from 40